En

Management Team

Home Management Team

Management Team

Precisio Biotix is made up of top global scientific talent in Lysin/Phage field plus experienced Pharma/Life science entrepreneur and senior executives

  • Mark Engel

    Chairman and CEO

    Founded: Five successful life science companies since 1990; rich experience in new drug registrations and product commercialization

    Companies established: NPO Pharmaceutical (sold), Excel PharmaStudies company (sold), Tiger Medical Group (sold), Haoyisheng ("Good Doctor” largest shareholder, Director), and Phagelux AgriHealth Inc. (largest shareholder, Chairman)

    Mark established his own investment fund, Tianshi Capital, which invests in life science and agricultural companies. See further information at: www.tianshicapital.com

  • Dr. Bryan Li 

    EVP Medical

    Trained dermatologist (China, Korea, US)

    25 years of China and international pharmaceutical experience

    Held senior medical positions at Avon, GSK Consumer, Unilever and Sanofi

  • Dr. Assaf Raz

    Chief Scientific Officer

    Globally-recognized Key Opinion Leader in lysin science

    Highly published

    Holds numerous lysin patents

    PhD Microbiology (Rockefeller University)  Post-doctorate with Dr. Fischetti

  • Dr. Raymond Schuch 

    VP, Director of US Operations

    Founding member of initial Lysin discovery group at Rockefeller University (PhD Microbiology, post-doc)

    World expert and KOL in discovery and clinical development of Lysins and Direct Lytic Agents

    Over 75 peer-reviewed publications, 25+ patents, PI on multiple government and private grants

    Generated platform technology and robust pipeline  

    Former Head of Research at ContraFect Corp

    Phase 1-3 clinical trial development

  • Dr. Nancy Tawil 

    VP of R&D

    Globally-recognized KOL in phages and bioengineering

    PhD Bioengineering (Ecole Polytechnique de Montreal)

    Industry expert in nanotechnology, surface chemistry, polymer chemistry, and phages

    Downstream formulation expert

    GMP manufacture

  • Dr. Mya Thandar

    Director, Zeus™- LysiThru™

    Noted industry leader in creating novel lysins

    PhD Microbiology (Rockefeller University) Post-doctorate with Dr. Fischetti

    HTP Assay development expert

    Gram-negative specialist

    Developed multiple novel patentable lysins

  • Dr. Matthew Cummings

    CEO, CC Bio

    Serial entrepreneur: founded two biotech start-ups from pre-idea to seed stage

    Leads CC Bio vision, fundraising, and BD strategy 

    Patents in endolysin and CRISPR-Cas fields

    PhD Synthetic Biology (Manchester) – harnessing synbio/automation for novel antimicrobial development

    Conceptualised and built Zeus™ platform

  • Dr David Corcoran .

    COO, CC Bio

    Registered Pharmacist

    Experienced Biotech Operations Leader

    PhD Medicinal Chemistry (King’s College London)

    Multiple endolysin publications

    Successful non-dilutive fundraiser and project manager. Maintains commercial focus of Zeus™

Copyright 1920-1921  PrecisioBiotix

Copyright © PrecisioBiotix support: 极速建站